Get breaking news and analysis on Proteostasis Therapeutics, Inc. (PTI) stock, price quote and chart, trading and investing tools. PTI Proteostasis Therapeutics, Inc. daily Stock Chart 07:36AM, The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Proteostasis Therapeutics Inc (NASDAQ: PTI) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance Based on 3 Wall Street analysts offering stock ratings for Proteostasis Therapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts
PTI.A - Proteostasis Therapeutics Inc Profile | Reuters Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and Proteostasis Therapeutics (PTI) Stock: Flying On FDA News ... Mar 13, 2018 · PTI-428 can potentially be added to current and future standards of care, offering the potential for improvement in pulmonary function for patients with cystic fibrosis.
Oct 24, 2018 · Proteostasis Therapeutics (NASDAQ:PTI) has priced an underwritten public offering of 11M common stock at $6.75 per share for estimated gross proceeds of ~$74.3M.Underwriters over-allotment is an addi PTI -- Is Its Stock Price A Worthy Investment? Learn More. PTI Stock Summary. For PTI, its debt to operating expenses ratio is greater than that reported by only 0.34% of US equities we're observing. PTI's price/sales ratio is 13.04; that's higher than the P/S ratio of 93.01% of US stocks. Proteostasis Therapeutics, Inc. Common Stock (PTI) Analyst ... Mar 27, 2020 · Based on analysts offering 12 month price targets for PTI in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and … Proteostasis Therapeutics Prices Public Offering of Common ...
Find the latest Proteostasis Therapeutics, Inc. (PTI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Proteostasis Therapeutics, Inc. Common Stock (PTI) SEC ... Find the latest SEC Filings data for Proteostasis Therapeutics, Inc. Common Stock (PTI) at Nasdaq.com. Proteostasis Therapeutics Announces Proposed Public ... As part of this offering, Proteostasis intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent, or 1,350,000 shares, of the common stock offered in the PTI News: Earnings, Analyst Moves, and More - Stock News
Proteostasis intends to use the net proceeds from the proposed offering to fund critical path activities for PTI-428 as an add on to standard of care and continue the advancement of PTI Proteostasis Therapeutics, Inc. (PTI) Stock Forum ... Find the latest Proteostasis Therapeutics, Inc. (PTI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Proteostasis Therapeutics, Inc. Common Stock (PTI) SEC ... Find the latest SEC Filings data for Proteostasis Therapeutics, Inc. Common Stock (PTI) at Nasdaq.com. Proteostasis Therapeutics Announces Proposed Public ... As part of this offering, Proteostasis intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent, or 1,350,000 shares, of the common stock offered in the